Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
3
×
genentech
3
×
life sciences
national blog main
national top stories
san francisco top stories
boston blog main
boston top stories
deals
eli lilly
investing
national
new york top stories
roche
san francisco blog main
4d molecular therapeutics
abbvie
acne
agenus
astrazeneca
auris health
avapritinib
avexis
bayer
billy dunn
biogen
biomx
bladder cancer
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
What
drug
3
×
fda
approved
roche
approval
atrophy
bio
blueprint
cancer
candidate
companies
currently
daily
digital
disease
epidemic
evrysdi
fatty
frenzied
friday
green
growing
home
intended
known
led
lights
liquid
liver
marketing
medicine
medicines
merck
muscle
muscular
nash
new
news
oral
pact
Language
unset
Current search:
genentech
×
drug
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
